Rowan Hillson Inpatient Safety Award 2022 application - winner & highly commended
Winner of Rowan Hillson Award 2022
Improving and sustaining improvement in diabetes-related ketoacidosis management through Quality Improvement Project across hospitals during COVID
Dr Punith Kempegowda on behalf of the DEKODE team
University Hospitals Birmingham NHS Foundation Trusts, Mindelsohn way, Edgbaston, Birmingham, B152TH
National Diabetes Audit: Submission update
This is a reminder that the submission deadline for specialist/secondary diabetes services as part of the National Diabetes Audit (NDA) is Thursday 30th June 2022 at 11:59.
Submissions of data (for all patients attending specialist services between 1 January 2021 and 31 March 2022) should be completed before this cut-off date.
Winners of the Rowan Hillson Inpatient Safety Award 2022: The best interventions: Redesigning, rebuilding, and maintaining safe inpatient diabetes care during COVID
This is to announce the results of this national competition for the ‘Best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID. One winner and one highly commended were identified. There were 5 entries, and we are very grateful to Dr Rowan Hillson and her fellow judges, Dr Clare Crowley, Esther Walden, Dr Rose Stewart, Professor Gerry Rayman and Dr Susannah Rowles for their time in judging these submissions.
On Demand webinar: 40% of men with type 2 diabetes have symptomatic testosterone deficiency – why are we still not finding and treating these men?
In the fourth of our 2022 ABCD webinar series, please join Dr Bob Ryder and Professor Hugh Jones to discuss symptomatic testosterone deficiency.
National Clinical Impact Awards 2022 - open for applications
The Advisory Committee on Clinical Impact Awards (ACCIA), formerly ACCEA, has opened the 2022 application round.
MHRA: April Drug Safety Update on Pregabalin (Lyrica)
The MHRA has published a Drug Safety Update on pregabalin (Lyrica) and the findings of a safety study on risks if used during pregnancy.
We have also produced a Safety leaflet to help patients to understand the latest information about the effects of pregabalin during pregnancy.